This recertification of Company's OECD GLP is testimony to company's unwavering commitment to maintain international quality standards at the facility
The FDA issued Form 483 with one observation related to building and facility management
Niacin is indicated to reduce elevated total cholesterol, LDL cholesterol, apolipoprotein B and triglycerides (TG)
Vimta Labs has reported total income of Rs. 96.08 crores during the period ended March 31, 2025
This partnership marks a significant milestone in Sigachi's strategy to expand into advanced drug delivery technologies.
The Subsidiary has received one inspectional observation in Form 483
Alembic Pharmaceuticals commissions new facility at Pithampur
This Product is indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension
ekincare has raised a total funding of $22M since 2015 till date
The company has posted net profit of Rs. 406.7 crores for the Financial Year ended March 31, 2025
Subscribe To Our Newsletter & Stay Updated
